Uniname Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 05-01-2025
- Paid Up Capital ₹ 0.15 M
as on 05-01-2025
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 72.76%
(FY 2020)
- Profit 71.54%
(FY 2020)
- Ebitda 32.84%
(FY 2020)
- Net Worth 18.69%
(FY 2020)
- Total Assets 7.26%
(FY 2020)
About Uniname Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Meena Jain and Bharat Shah serve as directors at the Company.
- CIN/LLPIN
U85110MP2007PTC020033
- Company No.
020033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uniname Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meena Jain  | Director | 28-Nov-2007 | Current |
| Bharat Shah | Director | 28-Nov-2007 | Current |
Financial Performance of Uniname Diagnostics.
Uniname Diagnostics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 72.76% increase. The company also saw a substantial improvement in profitability, with a 71.54% increase in profit. The company's net worth Soared by an impressive increase of 18.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uniname Diagnostics?
In 2019, Uniname Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uniname Diagnostics?
Unlock and access historical data on people associated with Uniname Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniname Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniname Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
